EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial

Federica Sabia, Maurizio Balbi iD, Roberta E Ledda, Gianluca Milanese, Margherita Ruggirello, Camilla Valsecchi, Alfonso Marchianò, Nicola Sverzellati, Ugo Pastorino iD

PLOS ONE · 16.05.2023 · 18 (5) · e0285593

DOI: 10.1371/journal.pone.0285593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 16.05.2023. Verfasst von Federica Sabia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Coronary Artery Disease, Lung Neoplasms, Vascular Calcification. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery calcium (CAC) is a known risk factor for cardiovascular (CV) events and mortality but is not yet routinely evaluated in low-dose computed tomography (LDCT)-based lung cancer screening (LCS). The present analysis explored the capacity of a fully automated CAC scoring to predict 12-year mortality in the Multicentric Italian Lung Detection (MILD) LCS trial. The study included 2239 volunteers of the MILD trial who underwent a baseline LDCT from September 2005 to January 2011, with a median follow-up of 190 months. The CAC score was measured by a commercially available fully automated artificial intelligence (AI) software and stratified into five strata: 0, 1–10, 11–100, 101–400, and > 400. Twelve-year all-cause mortality was 8.5% (191/2239) overall, 3.2% with CAC = 0, 4.9% with CAC = 1–10, 8.0% with CAC = 11–100, 11.5% with CAC = 101–400, and 17% with CAC > 400. In Cox proportional hazards regression analysis, CAC > 400 was associated with a higher 12-year all-cause mortality both in a univariate model (hazard ratio, HR, 5.75 [95% confidence interval, CI, 2.08–15.92] compared to CAC = 0) and after adjustment for baseline confounders (HR, 3.80 [95%CI, 1.35–10.74] compared to CAC = 0). All-cause mortality significantly increased with increasing CAC (7% in CAC ≤ 400 vs. 17% in CAC > 400, Log-Rank p-value 400 (Grey’s test p < 0.001). In Fine and Gray’s competing risk model, CAC > 400 predicted 12-year non-cancer mortality in a univariate model (sub-distribution hazard ratio, SHR, 10.62 [95% confidence interval, CI, 1.43–78.98] compared to CAC = 0), but the association was no longer significant after adjustment for baseline confounders. In conclusion, fully automated CAC scoring was effective in predicting all-cause mortality at 12 years in a LCS setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseLung NeoplasmsVascular CalcificationHumansCalciumEarly Detection of CancerArtificial IntelligenceRisk AssessmentRisk Factors

Substanzen

Calcium

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Section of Radiology, Department of Medicine and Surgery (DiMeC), University Hospital of Parma, Parma, Italy.
  • Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

ORCID-Profile: Maurizio Balbi, Ugo Pastorino

Förderung

  • NCI NIH HHS
  • Ministero della Salute
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Cariplo
  • National Cancer Institute

Zitieren

APA

Sabia, F., Balbi, M., Ledda, R. E., Milanese, G., Ruggirello, M., Valsecchi, C., Marchianò, A., Sverzellati, N., & Pastorino, U. (2023). Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial. PLOS ONE, 18(5), e0285593. https://doi.org/10.1371/journal.pone.0285593

Vancouver

Sabia F, Balbi M, Ledda RE, Milanese G, Ruggirello M, Valsecchi C, et al. Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial. PLOS ONE. 2023;18(5):e0285593. doi:10.1371/journal.pone.0285593

BibTeX
@article{Sabia2023,
  author = {Sabia, Federica and Balbi, Maurizio and Ledda, Roberta E and Milanese, Gianluca and Ruggirello, Margherita and Valsecchi, Camilla and Marchianò, Alfonso and Sverzellati, Nicola and Pastorino, Ugo},
  title = {Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {5},
  pages = {e0285593},
  doi = {10.1371/journal.pone.0285593}
}
Kostenlos starten →